Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$289K Sell
6,194
-62
-1% -$2.87K ﹤0.01% 669
2026
Q1
$307K Sell
6,256
-173
-3% -$8.05K ﹤0.01% 645
2025
Q4
$280K Sell
6,429
-311
-5% -$14.2K ﹤0.01% 677
2025
Q3
$303K Sell
6,740
-104
-2% -$4.57K ﹤0.01% 658
2025
Q2
$297K Buy
6,844
+955
+16% +$42.5K ﹤0.01% 634
2025
Q1
$271K Sell
5,889
-333
-5% -$13.9K ﹤0.01% 599
2024
Q4
$234K Sell
6,222
-4,541
-42% -$176K ﹤0.01% 588
2024
Q3
$373K Buy
10,763
+2,588
+32% +$97.3K ﹤0.01% 578
2024
Q2
$307K Buy
8,175
+1,883
+30% +$69.5K ﹤0.01% 548
2024
Q1
$236K Buy
6,292
+2,196
+54% +$78.5K ﹤0.01% 454
2023
Q4
$155K Buy
4,096
+516
+14% +$19.9K ﹤0.01% 529
2023
Q3
$146K Buy
3,580
+358
+11% +$14.6K ﹤0.01% 513
2023
Q2
$135K Sell
3,222
-1,497
-32% -$61.9K ﹤0.01% 441
2023
Q1
$204K Buy
4,719
+554
+13% +$23.1K ﹤0.01% 534
2022
Q4
$156K Buy
4,165
+567
+16% +$22.4K ﹤0.01% 535
2022
Q3
$163K Buy
3,598
+1,076
+43% +$47.6K ﹤0.01% 381
2022
Q2
$120K Buy
+2,522
New +$119K ﹤0.01% 445

Other funds holding EXC

Blue Trust Inc's EXC Position: Q2 2026 in Review

Blue Trust Inc reduced its Exelon (EXC) stake by 0.99% in Q2 2026, selling an estimated $2.87K and leaving 6,194 shares worth $289K. The position accounts for ﹤0.01% of the portfolio, ranked #669.

Blue Trust Inc first reported a position in EXC in Q2 2022 and has held it in 17 quarters since. The position peaked at $373K in Q3 2024. 1,286 funds tracked by Wall St. Rank hold EXC as of Q2 2026.

  • Blue Trust Inc held 6,194 shares of Exelon worth $289K as of Q2 2026.
  • Blue Trust Inc sold 62 Exelon shares in Q2 2026, an estimated $2.87K.
  • Exelon made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #669 holding.
  • Blue Trust Inc first reported a position in Exelon in Q2 2022 and has held it in 17 quarters since.
  • Blue Trust Inc's Exelon position peaked at $373K in Q3 2024.
  • 1,286 funds tracked by Wall St. Rank held Exelon as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.